| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.014 | 0.8 |